Tag: Prescription Drugs
Androgen-Deprivation Therapy May Carry Cardiovascular Risks
Findings in men with clinically localized prostate cancer initially under active surveillance
No Reduction in Composite End Point for Bivalirudin in PCI
Patients receiving bivalirudin vs heparin saw no reduction in composite of death, MI, major bleeding
Dual Therapy Noninferior to Triple Therapy for A-Fib With PCI
And lower risk of bleeding with dabigatran and P2Y12 inhibitor dual therapy versus triple therapy
Canakinumab 150 mg Tied to Reduced Rate of Cardiac Events
150-mg dose met prespecified threshold for significance for primary and secondary end points
Diacerein Reduces Mean Hemoglobin A1c Levels in T2DM
Peak of effect occurred at 24th week of treatment; attenuated toward nonsignificance at 48th week
ART Era Has Changed Secondary Cancers After Kaposi Sarcoma
Certain cancers -- ALL and cancers of the tongue, penis -- becoming more common
More Evidence Evolocumab Exceeds Cost-Effectiveness
Findings for addition of evolocumab to standard tx in atherosclerotic cardiovascular disease
Noninvasive Test for NASH, Fibrosis in Patients With Psoriasis
Correlation for cumulative methotrexate dose with higher score on NASH FibroSure in women
Opioids Often Prescribed Unnecessarily for Migraine
And many patients may not be getting recommended medications
No Increase in Acute Kidney Injury Risk for SGLT2 Users
Using data from two health systems, no increased risk seen in AKI, even after adjustment for covariates
